WNT5A and pancreatic neoplasm: Zhou et al. [31] demonstrated that the maturation and function of bone marrow-derived dendritic cells are significantly inhibited by upregulation of FOXM1 through the Wnt5a signaling pathway in pancreatic cancer and colon cancer.